Longaeva Partners’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
Longaeva Partners's ARCT Position: Q3 2026 in Review
Longaeva Partners opened a new position in Arcturus Therapeutics (ARCT) in Q3 2026: 245,653 shares worth $3.36M. The stake represents 0.07% of the portfolio and ranks #211 among its holdings.
155 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.
- Longaeva Partners held 245,653 shares of Arcturus Therapeutics worth $3.36M as of Q3 2026.
- Arcturus Therapeutics was a new Longaeva Partners position in Q3 2026.
- Arcturus Therapeutics made up 0.07% of Longaeva Partners's portfolio in Q3 2026, its #211 holding.
- 155 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.